Breaking News Instant updates and real-time market news.

2023-03-08 12:13:14 WJXFF Wajax $18.52 / +0.767 (+4.32%) 12:13 03/08/23 03/08 12:13 03/08/23 12:13	Wajax price target raised to C$31 from C$27 at TD Securities TD Securities raised the firm's price target on Wajax to C$31 from C$27 and keeps a Buy rating on the shares.

2023-03-08 12:13:14

WJXFF

Wajax

$18.52 / +0.767 (+4.32%)

12:13

03/08/23

03/08

12:13

03/08/23

12:13

Wajax price target raised to C$31 from C$27 at TD Securities

TD Securities raised the firm's price target on Wajax to C$31 from C$27 and keeps a Buy rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Initiation	Bausch + Lomb assumed with an Equal Weight at Morgan Stanley » 06:52 05/30/23 05/30 06:52 05/30/23 06:52 BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) Morgan Stanley assumed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:52 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) 05/18/23 Bausch + Lomb and Novaliq announce FDA approval of Miebo 03/22/23 Bausch + Lomb, Novaliq announce publication of Phase 3 data on NOV03 02/15/23 Bausch + Lomb rises 12.8% 02/15/23 Bausch + Lomb names Brent Saunders as CEO, succeeding Joseph Papa BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) 05/22/23 Jefferies Bausch Health price target raised to $9.50 from $7 at Jefferies 05/19/23 H.C. Wainwright Bausch + Lomb price target raised to $22 from $19 at H.C. Wainwright 05/18/23 Wells Fargo Bausch + Lomb has 'significant opportunity' with Miebo, says Wells Fargo 05/17/23 RBC Capital District Court ruling positive for Bausch Health and Bausch + Lomb, says RBC BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) 05/03/23 Bausch + Lomb sees FY23 revenue $3.9B-$3.95B, consensus $5.32B 05/03/23 Bausch + Lomb Q1 adjusted EPS 10c vs. 24c last year 02/22/23 Bausch + Lomb reports Q4 adjusted EPS 23c vs. 35c a year ago BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) 12/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Initiation	Alcon assumed with an Equal Weight at Morgan Stanley » 06:51 05/30/23 05/30 06:51 05/30/23 06:51 ALC Alcon $79.06 / +0.78 (+1.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:51 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ALC Alcon $79.06 / +0.78 (+1.00%) 05/22/23 Lifecore enters into $150M new financing with Alcon 05/01/23 Alcon announces presence at ASCRS 2023 03/30/23 Sight Sciences defeats invalidity challenges filed by Alcon, Ivantis 02/13/23 Alcon to pay $199M in settlement agreement with J&J Surgical Vision ALC Alcon $79.06 / +0.78 (+1.00%) 05/24/23 Barrington Lifecore price target raised to $10 from $8 at Barrington 05/23/23 Stephens Lifecore 'now a much cleaner story,' says Stephens 05/11/23 JPMorgan Alcon price target raised to CHF 71 from CHF 63.80 at JPMorgan 05/11/23 Mizuho Alcon price target raised to $95 from $85 at Mizuho ALC Alcon $79.06 / +0.78 (+1.00%) 05/09/23 Alcon backs FY23 EPS view of $2.55-$2.65, consensus $2.59 05/09/23 Alcon reports Q1 EPS 70c, consensus 60c 02/27/23 Alcon sees FY23 EPS $2.55-$2.65, consensus $2.52 02/27/23 Alcon reports Q4 EPS 42c, consensus 42c ALC Alcon $79.06 / +0.78 (+1.00%) 05/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/27/23 Fly Intel: After-Hours Movers 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning
Recommendations	Google AI chip orders accelerating at Broadcom, says JPMorgan » 06:50 05/30/23 05/30 06:50 05/30/23 06:50 AVGO Broadcom $812.72 / +84.07 (+11.54%) , GOOG Alphabet $125.37 / +1.04 (+0.84%) , GOOGL Alphabet $124.62 / +1.14 (+0.92%) , META Meta Platforms $262.01 / +9.33 (+3.69%) JPMorgan analyst Harlan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:50 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 05/23/23 Broadcom up 2% after Apple announces 'multibillion-dollar' supply deal 05/23/23 Broadcom reports two separate multi-year statements of work with Apple 05/23/23 Apple reports 'multibillion-dollar' deal with Broadcom for U.S.-made components 04/18/23 Broadcom announces delivery of Jericho3-AI GOOG Alphabet $125.37 / +1.04 (+0.84%) 05/29/23 Fly Intel: Top five weekend stock stories 05/29/23 Nvidia announces DGX GH200 AI supercomputer 05/25/23 Google starts access to new generative AI capacity in Search 05/24/23 Pershing Square: In very early days of AI development GOOGL Alphabet $124.62 / +1.14 (+0.92%) 05/29/23 Fly Intel: Top five weekend stock stories 05/29/23 Nvidia announces DGX GH200 AI supercomputer 05/25/23 Google starts access to new generative AI capacity in Search 05/24/23 Pershing Square: In very early days of AI development META Meta Platforms $262.01 / +9.33 (+3.69%) 05/29/23 Fly Intel: Top five weekend stock stories 05/29/23 Nvidia announces DGX GH200 AI supercomputer 05/23/23 Shutterstock to acquire GIPHY from Meta Platforms for $53M 05/23/23 Shutterstock to acquire GIPHY from Meta Platforms for $53M AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 06:11 Today KeyBanc Broadcom price target raised to $820 from $720 at KeyBanc 05/26/23 Oppenheimer Broadcom price target raised to $800 from $720 at Oppenheimer 05/25/23 BofA Nvidia price target raised to $450 from $340 at BofA 05/25/23 Susquehanna Broadcom price target raised to $785 from $690 at Susquehanna GOOG Alphabet $125.37 / +1.04 (+0.84%) 06:11 Today KeyBanc Broadcom price target raised to $820 from $720 at KeyBanc 05/24/23 BofA Google's three pillars 'still upright' despite Bing in ChatGPT, says BofA 05/24/23 BofA Partnership with Waymo 'positive for Uber on several fronts,' says BofA 05/23/23 Jefferies Alphabet price target raised to $150 from $130 at Jefferies GOOGL Alphabet $124.62 / +1.14 (+0.92%) 06:11 Today KeyBanc Broadcom price target raised to $820 from $720 at KeyBanc 05/24/23 BofA Google's three pillars 'still upright' despite Bing in ChatGPT, says BofA 05/24/23 BofA Partnership with Waymo 'positive for Uber on several fronts,' says BofA 05/23/23 Jefferies Alphabet price target raised to $150 from $130 at Jefferies META Meta Platforms $262.01 / +9.33 (+3.69%) 05/23/23 Piper Sandler Meta's AI initiatives could drive revenue recapture, says Piper Sandler 05/23/23 Citi Citi sees minimal risk to Meta Platforms after E.U. data fine 05/22/23 Evercore ISI Meta, Spotify, Zillow removed from 'Tactical Outperform' list at Evercore ISI 05/19/23 Roth MKM Meta Platforms' capex may decline in 2023-2024, says Roth MKM AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 03/02/23 Broadcom sees Q2 revenue approximately $8.7B, consensus $8.59B 03/02/23 Broadcom reports Q1 adjusted EPS $10.33, consensus $10.10 03/02/23 VMware reports Q4 EPS $2.13, consensus $1.92 03/02/23 Notable companies reporting after market close GOOG Alphabet $125.37 / +1.04 (+0.84%) 04/25/23 Alphabet reports Q1 EPS $1.17, consensus $1.07 04/25/23 Alphabet reports Q1 Google Cloud revenue $7.45B vs. $5.82B last year 04/25/23 Alphabet reports Q1 EPS $1.17, consensus $1.07 04/25/23 Notable companies reporting after market close GOOGL Alphabet $124.62 / +1.14 (+0.92%) 04/25/23 Alphabet reports Q1 EPS $1.17, consensus $1.07 04/25/23 Alphabet reports Q1 Google Cloud revenue $7.45B vs. $5.82B last year 04/25/23 Alphabet reports Q1 EPS $1.17, consensus $1.07 04/25/23 Notable companies reporting after market close META Meta Platforms $262.01 / +9.33 (+3.69%) 05/21/23 Fly Intel: Top five weekend stock stories 04/26/23 Meta Platforms sees Q2 revenue $29.5B-$32B, consensus $29.48B 04/26/23 Meta Platforms reports Q1 EPS $2.20, consensus $2.53 04/26/23 Notable companies reporting after market close AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 03/04/23 Boom time for farmers can last, Deere stands to benefit, Barron's says 02/27/23 Broadcom set to receive EU warning over VMware deal, Reuters reports 02/13/23 Democrats want tighter limit on stock buybacks in chip subsidies, Bloomberg says 02/03/23 Broadcom CEO Tan plans to seek more acquisitions after VMware, FT reports GOOG Alphabet $125.37 / +1.04 (+0.84%) 05/26/23 Google ordered to pay Sonos $32.5M in patent infringement case, Verge says 05/25/23 YouTube to shut down Stories on June 26 amid focus on Shorts, TechCrunch says 05/24/23 DoorDash sued in $1B lawsuit for charging iPhone users more, NY Post reports 05/23/23 White House wants workers opinion on employers use of AI, Reuters reports GOOGL Alphabet $124.62 / +1.14 (+0.92%) 05/26/23 Google ordered to pay Sonos $32.5M in patent infringement case, Verge says 05/25/23 YouTube to shut down Stories on June 26 amid focus on Shorts, TechCrunch says 05/24/23 DoorDash sued in $1B lawsuit for charging iPhone users more, NY Post reports 05/23/23 Google to experiment with ads appearing directly in AI chatbot, TechCrunch says META Meta Platforms $262.01 / +9.33 (+3.69%) 05/25/23 Meta Platforms completes previously announced job cuts, Bloomberg reports 05/24/23 Meta Platforms starts next round of layoffs, CNBC reports 05/24/23 EU court dismisses Meta's challenge to hand over data, Bloomberg reports 05/23/23 White House wants workers opinion on employers use of AI, Reuters reports AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 05/23/23 What You Missed On Wall Street On Tuesday 05/23/23 What You Missed On Wall Street This Morning 04/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/03/23 What You Missed On Wall Street On Friday GOOG Alphabet $125.37 / +1.04 (+0.84%) 05/24/23 #SocialStocks: Meta fined EUR 1.2B in Ireland for infringing on data laws 05/17/23 #SocialStocks: Tech companies seek employees abroad after hiring freeze 05/15/23 What You Missed On Wall Street On Monday 05/15/23 What You Missed On Wall Street This Morning GOOGL Alphabet $124.62 / +1.14 (+0.92%) 05/24/23 #SocialStocks: Meta fined EUR 1.2B in Ireland for infringing on data laws 05/17/23 #SocialStocks: Tech companies seek employees abroad after hiring freeze 05/15/23 What You Missed On Wall Street On Monday 05/15/23 What You Missed On Wall Street This Morning META Meta Platforms $262.01 / +9.33 (+3.69%) 05/24/23 What You Missed On Wall Street On Wednesday 05/24/23 #SocialStocks: Meta fined EUR 1.2B in Ireland for infringing on data laws 05/24/23 What You Missed On Wall Street This Morning 05/23/23 What You Missed On Wall Street On Tuesday 06/14/23 2023 Semiconductor Bus Tour 06/01/23 Broadcom - AVGO 05/31/23 Meta Platforms Inc 06/02/23 Alphabet Inc. CL A 06/02/23 Alphabet Inc. CL C AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 05/26/23 Early notable gainers among liquid option names on May 26th 03/03/23 Early notable gainers among liquid option names on March 3rd 03/02/23 Broadcom options imply 2.8% move in share price post-earnings 01/10/23 Unusually active option classes on open January 10th GOOG Alphabet $125.37 / +1.04 (+0.84%) 05/11/23 Unusually active option classes on open May 11th 04/25/23 Alphabet options imply 4.8% move in share price post-earnings 03/16/23 Alphabet call buyer realizes 17% same-day gains 02/28/23 Notable open interest changes for February 28th GOOGL Alphabet $124.62 / +1.14 (+0.92%) 05/22/23 Notable open interest changes for May 22nd 05/16/23 Early notable gainers among liquid option names on May 16th 05/15/23 Unusually active option classes on open May 15th 05/15/23 Notable open interest changes for May 15th META Meta Platforms $262.01 / +9.33 (+3.69%) 05/22/23 Early notable gainers among liquid option names on May 22nd 04/28/23 Notable open interest changes for April 28th 04/27/23 Early notable gainers among liquid option names on April 27th 04/27/23 Notable open interest changes for April 27th
Hot Stocks	Pfizer's marstacimab shows significant efficacy in Phase 3 hemophilia trial » 06:49 05/30/23 05/30 06:49 05/30/23 06:49 PFE Pfizer $37.59 / -0.245 (-0.65%) Pfizer announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:49 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE Pfizer $37.59 / -0.245 (-0.65%) 05/26/23 Pfizer, BioNTech in agreement with EU to reduce COVID vaccine volumes 05/25/23 Pfizer confirms FDA approves Paxlovid for mild-to-moderate COVID-19 in adults 05/25/23 FDA approves Paxlovid for mild-to-moderate COVID-19 in adults 05/23/23 Moderna, BioNTech other Covid vaccine makers jump amid China Covid scare PFE Pfizer $37.59 / -0.245 (-0.65%) 05/23/23 Jefferies Jefferies says Pfizer oral GLP-1 safety and tolerability 'important to note' 05/22/23 Pfizer weight loss drug may be as effective, quicker than Ozempic, CNBC says 05/19/23 BofA AdComm support for Pfizer's infant RSV vaccine 'not surprising,' says BofA 05/16/23 Stifel Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel PFE Pfizer $37.59 / -0.245 (-0.65%) 05/02/23 Pfizer backs FY23 adjusted EPS view $3.25-$3.45, consensus $3.36 05/02/23 Pfizer reports Q1 adjusted EPS $1.23, consensus 98c 03/15/23 Royalty Pharma raises FY23 adjusted cash receipt guidance to $2.85B-$2.95B 01/31/23 Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44 PFE Pfizer $37.59 / -0.245 (-0.65%) 05/26/23 Health authorities to target next COVID shot to new strain, WSJ says 05/23/23 China's new Covid surge could result in 65M infections a week, Bloomberg says 05/14/23 Pfizer Pfizer, Stryker have strong growth prospects, Barron's says 05/10/23 BioNTech pancreatic cancer vaccine 'shows promise' in small trial, NYT says PFE Pfizer $37.59 / -0.245 (-0.65%) 05/16/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street This Morning 03/21/23 What You Missed On Wall Street On Tuesday 06/28/23 Biotech/Biopharma 06/28/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 06/02/23 Truist Hosted Company Events at 2023 ASCO Annual Meeting PFE Pfizer $37.59 / -0.245 (-0.65%) 05/24/23 Notable open interest changes for May 24th 05/23/23 Unusually active option classes on open May 23rd 05/23/23 Notable open interest changes for May 23rd 05/23/23 Unusual call flow in option market yesterday
Initiation	Baxter assumed with an Equal Weight at Morgan Stanley » 06:48 05/30/23 05/30 06:48 05/30/23 06:48 BAX Baxter $41.29 / -0.055 (-0.13%) Morgan Stanley assumed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BAX Baxter $41.29 / -0.055 (-0.13%) 05/23/23 Artivion's PerClot system granted FDA Premarket Application approval 05/09/23 GE HealthCare names James Saccaro as CFO 05/09/23 Baxter CFO Jay Saccaro leaving at end of May, Brian Stevens named interim 05/08/23 Baxter trading resumes BAX Baxter $41.29 / -0.055 (-0.13%) 05/01/23 Barclays Baxter price target raised to $58 from $54 at Barclays 04/28/23 Stifel Baxter price target raised to $54 from $45 at Stifel 04/28/23 Deutsche Bank Baxter price target raised to $50 from $40 at Deutsche Bank 04/28/23 TD Cowen Baxter price target raised to $50 from $45 at TD Cowen BAX Baxter $41.29 / -0.055 (-0.13%) 04/27/23 Baxter sees Q2 EPS 59c- 61c, consensus 60c 04/27/23 Baxter reports Q1 EPS 59c, consensus 49c 04/26/23 Notable companies reporting before tomorrow's open 04/26/23 Notable companies reporting before tomorrow's open BAX Baxter $41.29 / -0.055 (-0.13%) 05/08/23 Warburg, Advent in lead to acquire Baxter's biopharma unit, Reuters says 03/20/23 Thermo Fisher, Celltrion compete for Baxter's biopharma unit, Reuters says BAX Baxter $41.29 / -0.055 (-0.13%) 04/27/23 Fly Intel: Pre-market Movers 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 02/09/23 Fly Intel: Pre-market Movers BAX Baxter $41.29 / -0.055 (-0.13%) 05/22/23 Unusually active option classes on open May 22nd 02/21/23 Baxter call volume above normal and directionally bullish 02/09/23 Baxter put volume heavy and directionally bearish 01/24/23 Baxter put volume heavy and directionally bearish
Initiation	Becton Dickinson assumed with an Overweight at Morgan Stanley » 06:48 05/30/23 05/30 06:48 05/30/23 06:48 BDX Becton Dickinson $241.13 / -0.49 (-0.20%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly BDX Becton Dickinson $241.13 / -0.49 (-0.20%) 05/16/23 Becton Dickinson announces FDA clearance for BD Kiestra MRSA imaging application 04/03/23 Becton Dickinson names Michelle Quinn as general counsel 03/16/23 Becton Dickinson receives FDA clearance for BD Vaginal Panel 03/09/23 Moody's to appoint Vincent Forlenza chairman on April 18 BDX Becton Dickinson $241.13 / -0.49 (-0.20%) 05/08/23 Barclays Becton Dickinson price target raised to $284 from $282 at Barclays 05/05/23 Piper Sandler Becton Dickinson upgraded to Overweight after pullback at Piper Sandler 05/05/23 Piper Sandler Becton Dickinson upgraded to Overweight from Neutral at Piper Sandler 04/12/23 KeyBanc Becton Dickinson upgraded to Overweight from Sector Weight at KeyBanc BDX Becton Dickinson $241.13 / -0.49 (-0.20%) 05/04/23 Becton Dickinson ups FY23 adjusted EPS view to $12.10-$12.32 from $12.07-$12.32 05/04/23 Becton Dickinson reports Q2 EPS $2.86, consensus $2.74 02/02/23 Becton Dickinson ups FY23 adjusted EPS view to $12.07-$12.32 from $11.85-$12.10 02/02/23 Becton Dickinson reports Q1 adjusted EPS $2.98, consensus $2.68 BDX Becton Dickinson $241.13 / -0.49 (-0.20%) 05/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/12/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks	Team regains NYSE compliance » 06:47 05/30/23 05/30 06:47 05/30/23 06:47 TISI Team $8.10 / +1.08 (+15.38%) Team announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:47 Get Free Trial ShowHide Related Items >><< Company News TISI Team $8.10 / +1.08 (+15.38%) 05/25/23 Team secures stakeholder loans to refinance capital structure 12/21/22 Team completes one-for-ten reverse stock split 12/09/22 Team announces one-for-ten reverse stock split
Hot Stocks	Golden Minerals to effect 1-for-25 reverse stock split » 06:46 05/30/23 05/30 06:46 05/30/23 06:46 AUMN Golden Minerals / + Golden Minerals announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:46 Get Free Trial ShowHide Related Items >><< Company News Street Research AUMN Golden Minerals / + 04/18/23 Golden Minerals reports Q1 production from Rodeo mine 04/04/23 Golden Minerals announces improved terms for Velardena Properties concentrates 01/11/23 Golden Minerals reports Q4 payable gold production 2,398 oz Au AUMN Golden Minerals / + 03/24/23 Alliance Global Partners Golden Minerals price target lowered to 80c from $1.10 at Alliance Global 08/04/22 H.C. Wainwright Golden Minerals price target lowered to 60c from $1 at H.C. Wainwright
Recommendations	PayPal recent weakness should be bought, says Mizuho » 06:45 05/30/23 05/30 06:45 05/30/23 06:45 PYPL PayPal $60.22 / +0.835 (+1.41%) Mizuho analyst Dan Dolev… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:45 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PYPL PayPal $60.22 / +0.835 (+1.41%) 05/22/23 Venmo introduces Venmo Teen Account 05/08/23 PayPal reduces FY23 operating margin expansion view to 100bps from 125bps 05/08/23 PayPal CEO says still see many challenging issues 05/08/23 PayPal down 2% despite 'beat and raise' report PYPL PayPal $60.22 / +0.835 (+1.41%) 05/22/23 Bernstein PayPal price target lowered to $70 from $85 at Bernstein 05/19/23 Morgan Stanley Morgan Stanley says proposed 1099-K legislation 'incremental positive' for Block 05/12/23 Exane BNP Paribas PayPal downgraded to Neutral from Outperform at Exane BNP Paribas 05/11/23 Barclays PayPal price target lowered to $92 from $108 at Barclays PYPL PayPal $60.22 / +0.835 (+1.41%) 05/21/23 Fly Intel: Top five weekend stock stories 05/08/23 PayPal raises FY23 adjusted EPS view to about $4.95, consensus $4.36 05/08/23 PayPal sees Q2 EPS $1.15-$1.17, consensus $1.04 05/08/23 PayPal reports Q1 adjusted EPS $1.17, consensus 98c PYPL PayPal $60.22 / +0.835 (+1.41%) 05/21/23 Fintech should be scared as Apple reaches deeper into pockets, Barron's says 05/17/23 PayPal seeking buyers for Xoom money transfer service, The Information says 03/16/23 Thiel had $50M in Silicon Valley Bank before collapse, FT reports 02/03/23 Appeals court revives CFPB rule over fees for prepaid customers, Reuters says PYPL PayPal $60.22 / +0.835 (+1.41%) 05/17/23 What You Missed On Wall Street On Wednesday 05/17/23 What You Missed On Wall Street This Morning 05/12/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PYPL PayPal $60.22 / +0.835 (+1.41%) 05/10/23 Notable open interest changes for May 10th 05/08/23 PayPal options imply 6.9% move in share price post-earnings 04/12/23 Early notable gainers among liquid option names on April 12th 03/23/23 Unusually active option classes on open March 23rd
Recommendations	Lantheus selloff on competitor approval overdone, says Mizuho » 06:42 05/30/23 05/30 06:42 05/30/23 06:42 LNTH Lantheus $91.06 / -6.855 (-7.00%) Mizuho views… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:42 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/23/23 Lantheus announces payment to CVR holders of $1.15 per CVR 04/24/23 Lantheus, Point Biopharma announces FDA grants FTD for 177Lu-PNT2002 03/17/23 Lantheus appoints Paul Blanchfield as president, Dan Niedzwiecki as CAO 02/16/23 Lantheus presents data on piflufolastat F 18 at 2023 ASCO symposium LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/05/23 SVB Securities Lantheus price target raised to $127 from $120 at SVB Securities 05/05/23 Truist Lantheus price target raised to $125 from $115 at Truist 05/05/23 JMP Securities Lantheus price target raised to $130 from $120 at JMP Securities 05/05/23 Mizuho Lantheus price target raised to $125 from $115 at Mizuho LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/04/23 Lantheus sees 2023 adjusted EPS $5.45-$5.70, consensus $4.95 05/04/23 Lantheus sees Q2 adjusted EPS $1.25-$1.33, consensus $1.21 05/04/23 Lantheus reports Q1 adjusted EPS $1.47, consensus $1.26 02/23/23 Lantheus sees FY23 adjusted EPS $4.95 - $5.10, consensus $4.21 LNTH Lantheus $91.06 / -6.855 (-7.00%) 03/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/23/23 What You Missed On Wall Street On Thursday 02/23/23 What You Missed On Wall Street This Morning

Recommendations	Omega Healthcare price target lowered to $31 from $32 at Mizuho » 06:39 05/30/23 05/30 06:39 05/30/23 06:39 OHI Omega Healthcare $28.34 / +0.25 (+0.89%) Mizuho analyst Vikram… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OHI Omega Healthcare $28.34 / +0.25 (+0.89%) 01/24/23 Omega Healthcare trading resumes 01/24/23 Omega Healthcare trading halted, volatility trading pause 01/09/23 Omega Healthcare sees EBITDA declining in Q1 vs. Q4 OHI Omega Healthcare $28.34 / +0.25 (+0.89%) 05/03/23 Stifel Omega Healthcare price target lowered to $33 from $36 at Stifel 04/19/23 Wells Fargo Omega Healthcare initiated with an Overweight at Wells Fargo 01/13/23 Baird Omega Healthcare price target lowered to $29 from $32 at Baird 01/09/23 Credit Suisse Omega Healthcare downgraded to Underperform from Neutral at Credit Suisse OHI Omega Healthcare $28.34 / +0.25 (+0.89%) 05/02/23 Omega Healthcare reports Q1 adjusted FFO 66c, consensus 60c 02/02/23 Omega Healthcare reports Q4 adjusted FFO 73c, consensus 73c 06/05/23 Omega Healthcare Investors
Recommendations	Ventas price target lowered to $53 from $60 at Mizuho » 06:39 05/30/23 05/30 06:39 05/30/23 06:39 VTR Ventas $42.87 / +0.045 (+0.11%) Mizuho analyst Vikram… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VTR Ventas $42.87 / +0.045 (+0.11%) 04/24/23 Land & Buildings letter to Ventas notes significant NOI underperformance 01/23/23 Ventas names J. Justin Hutchens to additional role of chief investment officer VTR Ventas $42.87 / +0.045 (+0.11%) 04/25/23 Barclays Ventas price target lowered to $55 from $57 at Barclays 04/19/23 Wells Fargo Wells Fargo starts Ventas with Overweight on senior housing growth 04/19/23 Wells Fargo Ventas initiated with an Overweight at Wells Fargo 04/12/23 Credit Suisse Ventas price target lowered to $50 from $51 at Credit Suisse VTR Ventas $42.87 / +0.045 (+0.11%) 05/08/23 Ventas backs FY23 normalized FFO view $2.90-$3.04, consensus $2.96 05/08/23 Ventas reports Q1 normalized FFO 74c, consensus 70c 02/09/23 Ventas sees FY23 normalized FFO $2.90-$3.04, consensus $3.07 02/09/23 Ventas reports Q4 normalized FFO 73c, consensus 72c
Recommendations	Welltower price target lowered to $86 from $91 at Mizuho » 06:38 05/30/23 05/30 06:38 05/30/23 06:38 WELL Welltower $73.54 / -0.07 (-0.10%) Mizuho lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:38 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WELL Welltower $73.54 / -0.07 (-0.10%) 05/08/23 Brookdale Senior Living enters revised agreements with Welltower 05/02/23 Welltower reports SS NOI growth of 23.4% year-over-year in quarter 04/24/23 Land & Buildings letter to Ventas notes significant NOI underperformance 02/15/23 Welltower, Retirement Unlimited announce partnership WELL Welltower $73.54 / -0.07 (-0.10%) 05/24/23 Deutsche Bank Deutsche ups target on 'must-own' Welltower to $84 from $81 05/16/23 RBC Capital Welltower price target raised to $87 from $82 at RBC Capital 04/19/23 Wells Fargo Wells Fargo starts Ventas with Overweight on senior housing growth 04/19/23 Wells Fargo Welltower initiated with an Overweight at Wells Fargo WELL Welltower $73.54 / -0.07 (-0.10%) 05/03/23 Welltower reports Q1 normalized FFO 85c, consensus 82c 05/02/23 Welltower raises normalized FFO view to $3.39-$3.54 from $3.35-$3.53 02/15/23 Welltower sees FY23 normalized FFO $3.35-$3.53, consensus $3.57 02/15/23 Welltower reports Q4 normalized FFO 83c, consensus 82c WELL Welltower $73.54 / -0.07 (-0.10%) 12/07/22 Welltower 'obfuscating its distressed assets,' Hindenburg says in short report 12/07/22 Welltower short report published by Hindenburg Research WELL Welltower $73.54 / -0.07 (-0.10%) 04/11/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/05/23 Fly Intel: After-Hours Movers 02/03/23 Sell these stocks now, proven algorithm says 12/07/22 What You Missed On Wall Street On Wednesday WELL Welltower $73.54 / -0.07 (-0.10%) 04/06/23 Early notable gainers among liquid option names on April 6th
Recommendations	Xcel Energy price target lowered to $69 from $72 at Mizuho » 06:36 05/30/23 05/30 06:36 05/30/23 06:36 XEL Xcel Energy $64.34 / +0.06 (+0.09%) Mizuho analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:36 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options XEL Xcel Energy $64.34 / +0.06 (+0.09%) 02/22/23 Xcel Energy raises quarterly dividend by 6.7% to 52c per share 01/26/23 Xcel Energy, Form Energy team to deploy iron-air battery systems XEL Xcel Energy $64.34 / +0.06 (+0.09%) 04/05/23 BMO Capital Xcel Energy price target lowered to $73 from $74 at BMO Capital 03/17/23 Mizuho Xcel Energy price target lowered to $72 from $75 at Mizuho 12/14/22 Wells Fargo Xcel Energy price target raised to $76 from $69 at Wells Fargo 11/21/22 Credit Suisse Xcel Energy downgraded to Neutral from Outperform at Credit Suisse XEL Xcel Energy $64.34 / +0.06 (+0.09%) 05/19/23 Xcel Energy backs FY23 EPS guidance of $3.30-$3.40, consensus $3.38 04/27/23 Xcel Energy backs FY23 EPS view $3.30-$3.40, consensus $3.38 04/27/23 Xcel Energy reports Q1 EPS 76c, consensus 74c 04/05/23 Xcel Energy affirms FY23 EPS $3.30-$3.40, updates on MN rate case XEL Xcel Energy $64.34 / +0.06 (+0.09%) 03/24/23 Early notable gainers among liquid option names on March 24th 03/15/23 Early notable gainers among liquid option names on March 15th
Recommendations	C4 Therapeutics price target lowered to $10, transferred at Evercore ISI » 06:35 05/30/23 05/30 06:35 05/30/23 06:35 CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:35 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) 05/04/23 C4 Therapeutics announces key upcoming milestones 02/28/23 Tango Therapeutics appoints Crystal as President of Research, Development 02/23/23 C4 Therapeutics announces upcoming milestones 01/30/23 C4 Therapeutics announces first patient dosed in Phase 1/2 trial of CFT1946 CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) 05/08/23 H.C. Wainwright C4 Therapeutics price target lowered to $25 from $35 at H.C. Wainwright 03/28/23 BofA C4 Therapeutics price target lowered to $5 from $11 at BofA 02/24/23 Credit Suisse Credit Suisse ups C4 Therapeutics to Neutral on 'dramatically' improved outlook 02/24/23 Credit Suisse C4 Therapeutics upgraded to Neutral from Underperform at Credit Suisse CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) 05/04/23 C4 Therapeutics reports Q1 EPS (71c), consensus (75c) 02/23/23 C4 Therapeutics reports 2022 EPS ($2.62), consensus ($2.57) CCCC C4 Therapeutics $3.08 / -0.015 (-0.48%) 02/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/15/23 C4 Therapeutics, Inc.
Recommendations	Salesforce price target raised to $250 from $225 at Wells Fargo » 06:33 05/30/23 05/30 06:33 05/30/23 06:33 CRM Salesforce $215.46 / +5.58 (+2.66%) Wells Fargo raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:33 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CRM Salesforce $215.46 / +5.58 (+2.66%) 05/15/23 Third Point buys Alibaba, cuts AIG in Q1 05/15/23 Appaloosa takes stake in FedEx, exits Aptiv 05/15/23 Lone Pine boosts Salesforce stake, reduces Visa, Mastercard stakes 05/15/23 Starboard takes stake in Rogers Corp, boosts stake in Splunk CRM Salesforce $215.46 / +5.58 (+2.66%) 06:13 Today Canaccord Salesforce price target raised to $230 from $215 at Canaccord 05/26/23 Evercore ISI Workday price target raised to $240 from $225 at Evercore ISI 05/26/23 Citi Salesforce price target raised to $229 from $210 at Citi 05/25/23 Wedbush Salesforce price target raised to $230 from $220 at Wedbush CRM Salesforce $215.46 / +5.58 (+2.66%) 03/01/23 Salesforce guides initial FY24 EPS $7.12-7.14, consensus $5.84 03/01/23 Salesforce sees Q1 EPS $1.60-$1.61, consensus $1.32 03/01/23 Salesforce reports Q4 EPS $1.68, consensus $1.36 03/01/23 Notable companies reporting after market close CRM Salesforce $215.46 / +5.58 (+2.66%) 05/26/23 Shopify nominates Bret Taylor for board seat, The Information says 05/16/23 Tech companies resumed hiring foreign workers this week, Lee Fang reports 04/24/23 Microsoft would stop bundling Teams, Office to avoid formal EU probe, FT says 03/24/23 Salesforce considering further job cuts, COO tells Bloomberg CRM Salesforce $215.46 / +5.58 (+2.66%) 04/24/23 What Wall Street is saying about Microsoft ahead of earnings 03/27/23 What You Missed On Wall Street On Monday 03/27/23 What You Missed On Wall Street This Morning 03/24/23 What You Missed On Wall Street This Morning 05/31/23 Software Conference 05/31/23 Salesforce - CRM 06/08/23 Salesforce Inc CRM Salesforce $215.46 / +5.58 (+2.66%) 03/03/23 Unusually active option classes on open March 3rd 03/02/23 Early notable gainers among liquid option names on March 2nd 03/01/23 Salesforce options imply 6.7% move in share price post-earnings 01/27/23 Salesforce call buyer realizes 114% same-day gains
Upgrade	BofA upgrades ChargePoint to Buy with shares at all-time lows » 06:33 05/30/23 05/30 06:33 05/30/23 06:33 CHPT ChargePoint $8.50 / +0.175 (+2.10%) BofA analyst Alex Vrabel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:33 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CHPT ChargePoint $8.50 / +0.175 (+2.10%) 04/04/23 ChargePoint enters international agreement with ALD Automotive 03/03/23 ChargePoint falls -7.9% 03/03/23 ChargePoint falls -9.2% 02/23/23 Fisker names ChargePoint as North America partner for EV charging stations CHPT ChargePoint $8.50 / +0.175 (+2.10%) 06:05 Today BofA ChargePoint upgraded to Buy from Neutral at BofA 05/08/23 B. Riley ChargePoint price target lowered to $12 from $18 at B. Riley 05/02/23 Guggenheim ChargePoint initiated with a Neutral at Guggenheim 04/25/23 Stifel Wallbox price target lowered to $9 from $14 at Stifel CHPT ChargePoint $8.50 / +0.175 (+2.10%) 03/03/23 ChargePoint sees Q1 revenue $122M-$132M, consensus $152.5M 03/02/23 ChargePoint reports Q4 EPS (23c), consensus (17c) 12/01/22 ChargePoint narrows FY23 revenue view to $475M-$485M from $450M-$500M 12/01/22 ChargePoint sees Q4 revenue $160M-$170M, consensus $160.91M CHPT ChargePoint $8.50 / +0.175 (+2.10%) 02/10/23 DOT's coming EV charger rules may pressure Tesla to open network, Reuters says CHPT ChargePoint $8.50 / +0.175 (+2.10%) 05/08/23 What You Missed This Week in EVs and Clean Energy 05/02/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/27/23 What You Missed This Week in EVs and Clean Energy 03/22/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/01/23 ChargePoint - CHPT 07/18/23 ChargePoint Holdings Inc CHPT ChargePoint $8.50 / +0.175 (+2.10%) 05/26/23 ChargePoint Holdings put volume heavy and directionally bearish 05/18/23 ChargePoint Holdings put volume heavy and directionally bearish 05/10/23 Largest borrow rate increases among liquid names 05/05/23 Largest borrow rate increases among liquid names
Earnings	Skyline Champion reports Q4 EPS $1.00, consensus 93c » 06:32 05/30/23 05/30 06:32 05/30/23 06:32 SKY Skyline Champion $64.49 / +0.435 (+0.68%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:32 Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events SKY Skyline Champion $64.49 / +0.435 (+0.68%) 02/08/23 Craig-Hallum Skyline Champion price target raised to $78 from $65 at Craig-Hallum 02/08/23 RBC Capital Skyline Champion price target raised to $65 from $54 at RBC Capital 12/30/22 Wedbush Wedbush favors four homebuilding stocks heading into 2023 12/14/22 Barclays Skyline Champion downgraded to Equal Weight from Overweight at Barclays SKY Skyline Champion $64.49 / +0.435 (+0.68%) 02/06/23 Skyline Champion reports Q3 EPS $1.44, consensus 92c SKY Skyline Champion $64.49 / +0.435 (+0.68%) 02/06/23 Fly Intel: After-Hours Movers 05/31/23 20th Annual Institutional Investor Conference 09:00 Today Skyline Champion - SKY
Hot Stocks	SpringsWorks Therapeutics says Phase 2 nirogacestat trial fully enrolled » 06:31 05/30/23 05/30 06:31 05/30/23 06:31 SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) SpringWorks Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:31 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) 04/17/23 MapKure, SpringWorks, BeiGene present data from Phase 1a/1b study of BGB-3245 02/27/23 SpringsWorks announces FDA acceptance, priority review of nirogacestat NDA 12/27/22 SpringsWorks Therapeutics completes submission of nirogacestat NDA to FDA SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) 04/28/23 Barclays SpringsWorks Therapeutics price target lowered to $41 from $55 at Barclays 03/07/23 H.C. Wainwright SpringsWorks Therapeutics price target raised to $105 from $99 at H.C. Wainwright 01/02/23 Barclays Barclays views GSK acquisition interest as positive for oncology stocks 12/01/22 BofA SpringsWorks Therapeutics initiated with a Buy, $45 price target at BofA SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) 05/03/23 SpringsWorks Therapeutics reports Q1 EPS ($1.18), consensus ($1.25) 02/28/23 SpringsWorks Therapeutics reports Q4 EPS ($1.19), consensus ($1.22) SWTX SpringsWorks Therapeutics $27.79 / -2.18 (-7.27%) 04/22/23 Short Report: Bears pare exposure in crypto stocks as bitcoin slumps 06/02/23 Biotechnology--Pre-ASCO Reception 00:00 Today 4th Annual Oncology Innovation Summit: Insights for ASCO & EHA 08/27/23 PDUFA Date for Nirogacestat
Recommendations	ServiceNow price target raised to $665 from $586 at Bernstein » 06:30 05/30/23 05/30 06:30 05/30/23 06:30 NOW ServiceNow $537.41 / +5.65 (+1.06%) Bernstein analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:30 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NOW ServiceNow $537.41 / +5.65 (+1.06%) 05/18/23 Wipro enters into five-year business partnership with ServiceNow 05/18/23 Juniper, ServiceNow team to deliver end-to-end automation for networks 05/17/23 ServiceNow, Nvidia announce partnership 05/17/23 ServiceNow announces multiyear North American partnership with NHL NOW ServiceNow $537.41 / +5.65 (+1.06%) 05/26/23 Evercore ISI Workday price target raised to $240 from $225 at Evercore ISI 05/18/23 Barclays ServiceNow price target raised to $559 from $551 at Barclays 05/17/23 Goldman Sachs Goldman Sachs increasingly positive on ServiceNow after Analyst Day 05/17/23 Piper Sandler Piper says 'don't split hairs,' buy ServiceNow shares NOW ServiceNow $537.41 / +5.65 (+1.06%) 04/26/23 ServiceNow reports Q1 adjusted EPS $2.37, consensus $2.04 04/26/23 Notable companies reporting after market close 01/25/23 ServiceNow reports Q4 EPS 2.28, consensus $2.02 01/25/23 Notable companies reporting after market close NOW ServiceNow $537.41 / +5.65 (+1.06%) 05/17/23 What You Missed On Wall Street On Wednesday 05/17/23 What You Missed On Wall Street This Morning 04/04/23 What You Missed On Wall Street On Tuesday 04/04/23 What You Missed On Wall Street This Morning 05/31/23 Software Conference 06/01/23 ServiceNow, Inc. NOW ServiceNow $537.41 / +5.65 (+1.06%) 05/17/23 Unusually active option classes on open May 17th 05/10/23 Early notable gainers among liquid option names on May 10th 04/26/23 ServiceNow options imply 5.6% move in share price post-earnings 04/04/23 Early notable gainers among liquid option names on April 4th

Upgrade	SVB upgrades Elevation Oncology to Outperform on Claudin18.2 ADC SYSA180 data » 06:27 05/30/23 05/30 06:27 05/30/23 06:27 ELEV Elevation Oncology $5.00 / +1.99 (+66.11%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:27 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ELEV Elevation Oncology $5.00 / +1.99 (+66.11%) 04/17/23 Elevation Oncology presents EO-3021 preclinical PoC data 01/06/23 Elevation Oncology realigns resources, CEO resigns, cuts workforce by 30% ELEV Elevation Oncology $5.00 / +1.99 (+66.11%) 06:04 Today SVB Securities Elevation Oncology upgraded to Outperform from Market Perform at SVB Securities 11/10/22 JPMorgan Elevation downgraded to Underweight on more difficult path at JPMorgan 11/10/22 JPMorgan Elevation Oncology downgraded to Underweight from Neutral at JPMorgan 11/07/22 SVB Securities Elevation Oncology downgraded to Market Perform from Outperform at SVB Securities ELEV Elevation Oncology $5.00 / +1.99 (+66.11%) 05/15/23 Elevation Oncology reports Q1 EPS (72c), consensus (59c) 03/09/23 Elevation Oncology reports Q4 EPS (82c0, consensus (78c) 06/02/23 2023 ASCO Annual Meeting
Upgrade	Canadian Western Bank upgraded to Outperform from Sector Perform at RBC Capital » 06:26 05/30/23 05/30 06:26 05/30/23 06:26 CBWBF Canadian Western Bank $16.94 / -1.01 (-5.63%) RBC Capital analyst Darko… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:26 Get Free Trial ShowHide Related Items >><< Street Research CBWBF Canadian Western Bank $16.94 / -1.01 (-5.63%) 05:26 Today Barclays Canadian Western Bank price target lowered to C$26 from C$27 at Barclays 05/16/23 CIBC Canadian Western Bank price target lowered to C$28 from C$30 at CIBC 05/09/23 Barclays Canadian Western Bank price target lowered to C$27 from C$29 at Barclays 03/03/23 TD Securities Canadian Western Bank price target lowered to C$33 from C$34 at TD Securities
Initiation	Viridian Therapeutics initiated with an Outperform at RBC Capital » 06:25 05/30/23 05/30 06:25 05/30/23 06:25 VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:25 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) 05/08/23 Viridian Therapeutics partners with Enable Injections 04/12/23 Viridian Therapeutics CEO buys $101K in common stock 04/12/23 Viridian Therapeutics appoints Casciano as Chief Commercial officer 02/06/23 Viridian Therapeutics appoints Scott Myers as President, CEO VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) 05/10/23 Oppenheimer Viridian Therapeutics price target lowered to $40 from $45 at Oppenheimer 05/10/23 JMP Securities Viridian Therapeutics price target lowered to $44 from $46 at JMP Securities 04/17/23 Wells Fargo Viridian Therapeutics initiated with an Overweight at Wells Fargo 03/29/23 Stifel Viridian Therapeutics initiated with a Buy at Stifel VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) 05/09/23 Viridian Therapeutics reports Q1 EPS ($1.61), consensus ($1.02) 03/08/23 Viridian Therapeutics reports Q4 EPS ($1.13), consensus (73c) 17 Aug VRDN Viridian Therapeutics $23.73 / -0.095 (-0.40%) 12/19/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Initiation	Kenvue initiated with an Outperform at RBC Capital » 06:24 05/30/23 05/30 06:24 05/30/23 06:24 KVUE Kenvue $26.29 / -0.01 (-0.04%) , JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) RBC Capital initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:24 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 04/30/23 Fly Intel: Top five weekend stock stories JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 05/25/23 Legend: Type II variation application submitted to EMA for CARVYKTI 05/25/23 Bristol-Myers granted FDA Fast Track Designation for 3 milvexian indications 05/12/23 Protagonist and Janssen report data from preclinical studies of JNJ-2113 05/11/23 Johnson & Johnson reports 61.91% increase in ownership of Nano-X Imaging KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 06:21 Today BofA Kenvue initiated with a Buy at BofA 05:13 Today Exane BNP Paribas Kenvue initiated with a Neutral at Exane BNP Paribas 05:06 Today Citi Johnson & Johnson resumed with a Buy at Citi 05:02 Today JPMorgan JPMorgan starts Kenvue with Overweight on 'resilient growth' JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 05:06 Today Citi Johnson & Johnson resumed with a Buy at Citi 05:02 Today JPMorgan JPMorgan starts Kenvue with Overweight on 'resilient growth' 04:32 Today Goldman Sachs Kenvue initiated with a Neutral at Goldman Sachs 05/24/23 Piper Sandler Cooper Companies price target raised to $430 from $375 at Piper Sandler JNJ JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 04/18/23 Johnson & Johnson raises FY23 adjusted EPS to $10.60-$10.70 from $10.45-$10.65 04/18/23 Johnson & Johnson reports Q1 adjusted EPS $2.68, consensus $2.51 04/17/23 Notable companies reporting before tomorrow's open 02/28/23 Fate Therapeutics reports Q4 EPS (58c), consensus (86c) 04 May KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/03/23 Johnson & Johnson's Kenvue to price at $22 per share, Bloomberg says 04/30/23 J&J's Kenvue spinoff a rare IPO winner in moribund market, Barron's says JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 05/26/23 Health authorities to target next COVID shot to new strain, WSJ says 05/23/23 Amgen, J&J settle patent lawsuit over Stelara biosimilar, Reuters reports 05/10/23 New suitors showing interest in ShockWave Medical, Street Insider says 05/03/23 Johnson & Johnson's Kenvue to price at $22 per share, Bloomberg says KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/07/23 Opening Day: J&J's Kenvue jumps 20% in market debut JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 05/07/23 Opening Day: J&J's Kenvue jumps 20% in market debut 04/28/23 What You Missed On Wall Street On Friday 04/28/23 What You Missed On Wall Street This Morning 04/18/23 What You Missed On Wall Street On Tuesday 06/09/23 Biotechnology 06/02/23 2023 ASCO Annual Meeting KVUE JNJ KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/10/23 Four new option listings on May 10th JNJ Johnson & Johnson $154.34 / -0.0698 (-0.05%) 04/18/23 Unusually active option classes on open April 18th 04/06/23 Unusually active option classes on open April 6th 04/05/23 Early notable gainers among liquid option names on April 5th 04/05/23 Unusually active option classes on open April 5th
Initiation	Kenvue initiated with a Buy at BofA » 06:21 05/30/23 05/30 06:21 05/30/23 06:21 KVUE Kenvue $26.29 / -0.01 (-0.04%) BofA analyst Anna Lizzul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:21 Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Periodicals On The Fly Options KVUE Kenvue $26.29 / -0.01 (-0.04%) 04/30/23 Fly Intel: Top five weekend stock stories KVUE Kenvue $26.29 / -0.01 (-0.04%) 05:13 Today Exane BNP Paribas Kenvue initiated with a Neutral at Exane BNP Paribas 05:06 Today Citi Johnson & Johnson resumed with a Buy at Citi 05:02 Today JPMorgan JPMorgan starts Kenvue with Overweight on 'resilient growth' 04:53 Today Citi Kenvue initiated with a Neutral at Citi 04 May KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/03/23 Johnson & Johnson's Kenvue to price at $22 per share, Bloomberg says 04/30/23 J&J's Kenvue spinoff a rare IPO winner in moribund market, Barron's says KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/07/23 Opening Day: J&J's Kenvue jumps 20% in market debut KVUE Kenvue $26.29 / -0.01 (-0.04%) 05/10/23 Four new option listings on May 10th

Events

Earnings calls, analyst events, roadshows and more

TIGR
Today at 08:00

UP Fintech - TIGR Conference Calls
GOTU
Today at 08:00

Gaotu Techedu - GOTU Conference Calls
GLNG
Today at 08:00

Golar LNG - GLNG Conference Calls
BNR
Today at 08:00

Burning Rock Biotech - BNR Conference Calls
TCRR
Today at 08:00

TCR2 Therapeutics Inc. Firm Sponsored Meetings
MDWD
Today at 08:30

MediWound - MDWD Conference Calls
YTRA
Today at 08:30

Yatra - YTRA Conference Calls
Today at 09:00

FHFA House Price Index Y/Y: March 2023 Government Event
Today at 09:00

Case-Shiller Home Price Index: 20-City Adjusted M/M: March 2023 Government Event
Today at 09:00

Case-Shiller Home Price Index: 20-City Unadjusted M/M: March 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	AZTR X AZTR Azitra IPO Managers: ThinkEquity $4.50-5.50 2.4M Shares SXTP X SXTP 60 Degrees Pharmaceuticals IPO Managers: WallachBeth $4.30-6.30 1.415M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Wajax price target raised to C$31 from C$27 at TD Securities

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access